“The Committee will be inviting various Massachusetts cannabis industry stakeholders to testify.” Chief concerns include “proper channels of accountability within the agency structure.”
CCC receivership rejected, but hearings on other options slated for this fall
Commissioners acknowledge need for clarity on roles of chair, executive director
In testimony to joint cannabis committee, IG Jeffrey Shapiro explains reasons for proposed agency takeover, lays out potential path to receivership through legislature
Letter from Institute of Cannabis Science to lawmakers notes: “Our findings … show that fraudulent and harmful products reach consumers in Massachusetts.”
“The opioid epidemic has continually escalated in recent years, and despite commendable efforts by the Healey-Driscoll Administration, challenges in access to effective interventions persist.”
Cannabis regulators respond to criticism from state lawmakers—again
We are in need of urgent solutions, and the role that cannabis can play is not only compelling, it’s a practical, non-lethal and legal tool in the kit that we could be employing as a harm reduction method.
“The public deserves some accountability on why these issues have proven so hard to stamp out, and what long-term changes the agency is making to get its work done with more transparency and efficiency.”
“Lab shopping is widespread here … The financial incentives are strong and there are no real incentives for honesty or accuracy.”
